Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1320075
European Journal of Endocrinology, Vol 132, Issue 1, 75-81
Copyright © 1995 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niccoli, P.
Right arrow Articles by Conte-Devolx, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Niccoli, P.
Right arrow Articles by Conte-Devolx, B.

Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis

Patricia Niccoli, Philippe Brunet, Christa Roubicek, François Roux, Eric Baudin, Pierre-Jean Lejeune, Yvon Berland and Bernard Conte-Devolx

Niccoli P, Brunet P, Roubicek C, Roux F, Baudin E, Lejeune P-J, Berland Y, Conte-Devolx B. Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. Eur J Endocrinol 1995;132:75–81. ISSN 0804–4643

Hypercalcitoninemia has been reported in renal failure. Using a specific monomeric calcitonin (CT) immunoassay, we measured CT levels in 154 hemodialyzed patients. The relationship between CT and serum intact parathyroid hormone (PTH), gastrin, alkaline phosphatases, phosphate and calcium was studied. The pentagastrin test was performed in 26 patients exhibiting basal hypercalcitoninemia. Basal CT levels over 5.7 pmol/l (20 ng/l) were found in 25.3% of the patients and values higher than 26 pmol/l (90 ng/l) in 7.8%. Although CT is cleared by hemodialysis, post-dialysis CT levels either were unchanged or increased as compared with pre-dialysis values. This suggests that hypercalcitoninemia is not related to a decreased renal clearance, and that hemodialysis induces a specific regulatory pathway. None of the parameters studied were found to explain high CT levels. Of the patients with hypercalcitoninemia, 11.5% exhibited abnormal CT response to pentagastrin but no relationship between CT and phosphate, calcium and PTH levels was evidenced. Our findings confirm high CT monomer levels in renal failure. As there was no correlation with parameters classically involved in CT regulation, its physiological significance remains unclear. Abnormal CT response to pentagastrin raises the problem of its specificity as a tumoral marker with regard to medullary thyroid carcinoma.

B Conte-Devolx, Service d'Endocrinologie et Maladies Métaboliques, Hôpital de la Conception, 147 Bd Baille, Marseille 13385 cedex 05, France




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. d'Herbomez, P. Caron, C. Bauters, C. Do Cao, J.-L. Schlienger, R. Sapin, L. Baldet, B. Carnaille, J.-L. Wemeau, and the French Group GTE (Groupe des Tumeurs Endocrine
Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking
Eur. J. Endocrinol., December 1, 2007; 157(6): 749 - 755.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
U. Verga, S. Ferrero, L. Vicentini, T. Brambilla, V. Cirello, M. Muzza, P. Beck-Peccoz, and L. Fugazzola
Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?
Endocr. Relat. Cancer, June 1, 2007; 14(2): 393 - 403.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 European Society of Endocrinology.